-
公开(公告)号:US5952306A
公开(公告)日:1999-09-14
申请号:US783635
申请日:1997-01-14
申请人: George D. Hartman , Mark E. Duggan , James J. Perkins , Cecilia A. Hunt , Amy E. Krause , John H. Hutchinson , Benny C. Askew , Karen M. Brashear , Nathan C. Ihle
发明人: George D. Hartman , Mark E. Duggan , James J. Perkins , Cecilia A. Hunt , Amy E. Krause , John H. Hutchinson , Benny C. Askew , Karen M. Brashear , Nathan C. Ihle
IPC分类号: C07D213/55 , C07D213/56 , C07D213/68 , C07D213/73 , C07D213/74 , C07D213/75 , C07D277/40 , C07D401/04 , C07D401/12 , C07D471/04 , C07K5/023 , A61K38/05 , A61K38/06
CPC分类号: C07D213/73 , C07D213/55 , C07D213/56 , C07D213/68 , C07D213/74 , C07D213/75 , C07D277/40 , C07D401/04 , C07D401/12 , C07D471/04
摘要: Fibrinogen receptor antagonists having the formula ##STR1## for example ##STR2## which are useful for inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
摘要翻译: 具有例如可用于抑制纤维蛋白原与血小板结合并抑制血小板聚集的配方的纤维蛋白原受体拮抗剂。
-
公开(公告)号:US20080249106A1
公开(公告)日:2008-10-09
申请号:US12082076
申请日:2008-04-08
申请人: Benny C. Askew , Jian J. Chen , Derin C. D'Amico , Thomas Nguyen , Kevin Yang
发明人: Benny C. Askew , Jian J. Chen , Derin C. D'Amico , Thomas Nguyen , Kevin Yang
IPC分类号: A61K31/496 , C07D249/06 , A61K31/4192 , A61K31/454 , C07D401/08 , C07D403/08
CPC分类号: C07C271/22 , C07C2603/18 , C07D249/04 , C07D295/135 , C07D311/68 , C07D405/04 , C07D405/06 , C07D405/14
摘要: The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
摘要翻译: 本发明包括新颖的化合物及其药学上可接受的衍生物,用于治疗由B1缓激肽受体介导的疾病的药物组合物和方法。
-
公开(公告)号:US20110282056A1
公开(公告)日:2011-11-17
申请号:US12811053
申请日:2009-01-20
申请人: Benny C. Askew , Nadia Brugger , Ruoxi Lan , Amanda E. Sutton
发明人: Benny C. Askew , Nadia Brugger , Ruoxi Lan , Amanda E. Sutton
IPC分类号: C07D471/04 , C07D401/14 , C07D413/14 , C07D487/04 , C07D495/04
CPC分类号: C07D471/04 , C07D213/73 , C07D213/76 , C07D487/04 , C07D495/04
摘要: Disclosed are compounds according to Formula I: wherein the variables are described herein.
摘要翻译: 公开了根据式I的化合物:其中变量在本文中描述。
-
公开(公告)号:US06645990B2
公开(公告)日:2003-11-11
申请号:US10077124
申请日:2002-02-15
申请人: Benny C. Askew , Frenel F. De Morin , Andrew Hague , Ellen Laber , Aiwen Li , Gang Liu , Patricia Lopez , Rana Nomak , Vincent Santora , Christopher Tegley , Kevin Yang
发明人: Benny C. Askew , Frenel F. De Morin , Andrew Hague , Ellen Laber , Aiwen Li , Gang Liu , Patricia Lopez , Rana Nomak , Vincent Santora , Christopher Tegley , Kevin Yang
IPC分类号: C07D21126
CPC分类号: C07D213/75 , C07D231/12 , C07D233/56 , C07D249/08 , C07D417/04 , C07D417/12 , C07D417/14 , C07D453/06 , C07D471/04 , C07D491/10
摘要: Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
-
-
-